Drugs with this side effect
- 1,25(OH)2D3
- 5-ASA: postmarketing, 2%
- 5-FU
- A77 1726: 1%
- CAS 76095-16-4
- CAS 76420-72-9: postmarketing
- Enfuvirtide: 1.9% - 4.1%
- Fe(III: 0% - 2.7%
- Gd-DTPA
- Gd-EOB-DTPA
- Ge-132
- K779: 2% - 5%
- L-Dmp: infrequent
- Metrodin
- NTBC: common
- Nafarelin
- Octreotide
- Optison
- PEP005
- TlCl
- Triptorelin: 1.1%
- UDCA
- abacavir
- abacavir-lamivudine
- acebutolol
- acitretin: postmarketing
- acyclovir: common
- adapalene
- afatinib: common, 0% - 11%
- allopurinol: postmarketing
- almotriptan: rare
- amlodipine
- amlodipine besylate
- amphotericin B
- anagrelide: 1-5%
- anthracycline
- apraclonidine: postmarketing
- aprepitant
- aripiprazole
- atomoxetine: uncommon
- atropine
- auranofin
- azelastine
- betaxolol: postmarketing
- bexarotene: 10%
- bicalutamide
- bisoprolol: very rare, postmarketing
- boceprevir: uncommon
- bortezomib
- bosentan
- bretylium
- brimonidine: uncommon
- brinzolamide: postmarketing
- budesonide: 1% - 4%
- buprenorphine
- bupropion
- buspirone: infrequent
- cabazitaxel
- cabozantinib
- candesartan cilexetil
- capecitabine: 1% - 6%
- carbamazepine: very rare
- cefaclor
- cefdinir: postmarketing
- celecoxib
- cetirizine
- cevimeline: 4.3%
- ciclesonide
- cidofovir
- cilazapril
- cilostazol
- ciprofloxacin: rare
- cisplatin
- citalopram: infrequent, uncommon
- cladribine: uncommon
- clarithromycin: common, 1.1%
- clomipramine: 1%
- clopidogrel
- copolymer 1
- cyclopentolate
- cyclophosphamide: postmarketing
- cytarabine: 80%
- dasatinib
- delavirdine
- delta 9-THC
- deprenyl: infrequent
- desflurane
- desmopressin: 0% - 2%
- dexamethasone: 2.44% - 5.86%
- diatrizoate
- diazepam
- diclofenac: 0% - 4%
- dihydroergotamine: infrequent
- diltiazem: 0% - 2.04%
- dimercaprol
- docetaxel: postmarketing, rare, 0% - 1.1%
- domperidone
- donepezil: infrequent
- dorzolamide
- doxazosin: 1% - 1.2%
- doxercalciferol
- doxorubicin: postmarketing, common, 0% - 38.4%
- doxycycline
- duloxetine: infrequent
- eletriptan: infrequent
- entacapone
- eprosartan
- eribulin
- erlotinib: 0% - 18%
- esomeprazole magnesium
- estradiol: 0% - 3.33%
- etodolac: postmarketing
- etoricoxib
- etravirine
- everolimus: uncommon, 2%
- felbamate
- fenofibrate: 1.05%
- fentanyl
- flunisolide
- fluorometholone
- fluoxetine: infrequent
- flurbiprofen
- fluticasone
- fluticasone furoate: 2.98%
- fluticasone propionate: postmarketing
- fluvastatin
- fluvoxamine: rare, infrequent
- formoterol
- fosaprepitant
- fosaprepitant dimeglumine
- foscarnet
- fosphenytoin: infrequent
- frovatriptan: infrequent
- gabapentin: infrequent, 0% - 1.2%
- gadobenate dimeglumine: postmarketing
- gadolinium: postmarketing
- gadopentetate
- gadoversetamide
- ganciclovir
- gatifloxacin
- gefitinib: 0.98% - 9.43%
- gliclazide: 0.8% - 1%
- glipizide
- glycerol
- guanfacine
- homatropine
- hydralazine: uncommon
- hydrochlorothiazide
- ibuprofen
- ifosfamide: postmarketing
- iloperidone
- imatinib: common, 0% - 7.6%
- imiquimod
- indapamide: 1%
- insulin detemir: 0.7% - 1.1%
- iodixanol
- iopamidol
- iopromide: postmarketing
- ioversol
- ioxilan
- ipratropium bromide
- irbesartan
- iron sucrose
- isomannide
- isopropyl unoprostone
- isosorbide-5-mononitrate
- ivermectin
- ketoprofen
- ketorolac: postmarketing
- ketorolac tromethamine
- lamotrigine: infrequent, 1%
- lansoprazole
- latanoprost: 1.1% - 3%
- leflunomide
- lenalidomide: common
- levetiracetam: 2% - 3%
- lomefloxacin
- losartan
- loteprednol etabonate
- malathion
- malvidin
- maraviroc: 1% - 2%
- meclofenamate: postmarketing
- medrysone
- mefenamic acid
- meloxicam: postmarketing
- memantine: frequent
- mephenytoin
- mesna
- methocarbamol
- methotrexate
- methylphenidate
- metipranolol
- metoprolol: rare
- metronidazole
- mirtazapine: infrequent
- misoprostol: postmarketing
- mitoxantrone: 0% - 5%
- moclobemide
- modafinil: 1%
- mometasone
- mometasone furoate
- montelukast
- morphine
- moxifloxacin
- mycophenolate mofetil
- mycophenolic acid
- nadolol
- naltrexone
- naproxen
- nedocromil sodium
- nefazodone: infrequent
- nevirapine: postmarketing
- nicardipine
- nicorandil
- nifedipine
- nilotinib: uncommon, common
- nisoldipine
- norfloxacin: postmarketing
- ofloxacin: postmarketing
- olanzapine: frequent
- olopatadine
- omeprazole
- oseltamivir: 1% - 5%
- oxaliplatin: common, very common, 1% - 15%
- oxaprozin
- oxybutynin
- paclitaxel: postmarketing, common
- paliperidone
- pamidronate: postmarketing, common
- pantoprazole: very rare
- paricalcitol
- paroxetine: infrequent, uncommon
- pegaptanib
- pegaptanib sodium
- pemetrexed: 0% - 1%
- pentamidine
- pentosan polysulfate
- pentostatin: 2% - 4%
- pentoxifylline
- pergolide: infrequent
- perindopril
- perindopril erbumine
- phencyclidine
- phenytoin: infrequent
- pilocarpine
- pindolol
- piroxicam
- pixantrone
- posaconazole
- pramipexole
- prednisolone
- prednisolone acetate
- pregabalin: frequent
- progesterone
- quetiapine: infrequent
- rabeprazole
- raloxifene: 2.2%
- raltitrexed: 2%
- ramipril
- rapamycin
- rasagiline: common, 3%
- reboxetine
- rescinnamine: 1.4%
- retinoic acid: postmarketing, 19%
- ribavirin: common, 32%
- rifampicin
- risedronate
- risperidone: 2.7%
- ritonavir
- rivastigmine: infrequent, frequent
- rofecoxib
- ropinirole: infrequent, frequent
- salbutamol: 1%
- salmeterol
- salmon calcitonin acetate
- saquinavir
- sertraline: infrequent
- sevoflurane
- sibutramine
- sildenafil
- sitaxsentan
- sodium ferric gluconate
- sparfloxacin
- stavudine
- sulindac
- sumatriptan: rare
- tacrolimus: 0% - 3%
- tadalafil
- telmisartan
- temsirolimus
- terazosin
- thalidomide
- thiotepa: 1-10%
- tiagabine
- tiaprofenic acid
- timolol: 1.1% - 3.5%
- tizanidine: infrequent, frequent
- topiramate: frequent, 0% - 7%
- tramadol
- travoprost: uncommon
- triamcinolone: 1.3% - 4.4%
- triamcinolone acetonide
- trovafloxacin
- unoprostone
- v 1784: postmarketing
- valdecoxib
- valproate
- vandetanib
- vardenafil
- varenicline: infrequent
- venlafaxine: infrequent
- verteporfin
- vigabatrin: 2% - 5%
- voriconazole
- zaleplon: frequent
- zileuton
- ziprasidone: infrequent
- zoledronic acid: postmarketing, common
- zolmitriptan: rare
- zolpidem: rare
- zonisamide: infrequent
- zopiclone: infrequent
|
Drugs with this indication
|
